New insulins and new insulin regimens: a review of their role in improving glycaemic control in patients with diabetes

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Postgraduate medical journal

• Publication date

  2009-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/pgmj.2008.067926PMID 19520878
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial.

  2008cited by this paper
• Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

  2008cited by this paper
• A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

  2008cited by this paper
• 10-year follow-up of intensive glucose control in type 2 diabetes.

  2008cited by this paper
• Initiate Insulin by Aggressive Titration and Education (INITIATE): A randomized study to compare initiation of insulin combination therapy in type 2 diabetic patients individually and in groups

  2008cited by this paper
• Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus.

  2007cited by this paper
• Advancing Insulin Therapy in Type 2 Diabetes Previously Treated With Glargine Plus Oral Agents

  2007cited by this paper
• Systematic literature review: quality of life associated with insulin pump use in Type 1 diabetes

  2007cited by this paper
• Insulin glulisine imparts effective glycaemic control in patients with Type 2 diabetes.

  2007cited by this paper
• A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naïve People With Type 2 Diabetes

  2007cited by this paper
• Use of insulin glargine during pregnancy: a case–control pilot study

  2007cited by this paper
• Comparison of insulin detemir and insulin glargine in subjects with Type 1 diabetes using intensive insulin therapy

  2007cited by this paper
• Infant and toddler diabetes

  2007cited by this paper
• Long-term Improvement of Metabolic Control Without Increased Risk of Hypoglycaemia by Intensive Insulin Regimens in Type 1 Diabetes Patients Treated in a Regular Clinical Setting

  2007cited by this paper
• Insulin treatment

  2007cited by this paper
• Continuing Stability of Center Differences in Pediatric Diabetes Care: Do Advances in Diabetes Treatment Improve Outcome?

  2007cited by this paper
• Negative binomial meta-regression analysis of combined glycosylated hemoglobin and hypoglycemia outcomes across eleven Phase III and IV studies of insulin glargine compared with neutral protamine Hagedorn insulin in type 1 and type 2 diabetes mellitus.

  2007cited by this paper
• Initiate Insulin by Aggressive Titration and Education (INITIATE)

  2007cited by this paper
• Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes.

  2007cited by this paper
• Triple Therapy in Type 2 Diabetes: Insulin Glargine or Rosiglitazone Added to Combination Therapy of Sulfonylurea Plus Metformin in Insulin-Naïve Patients

  2006cited by this paper
• ISPAD Clinical Practice Consensus Guidelines 2006–2007

  2006cited by this paper
• Emerging evidence for the use of insulin pump therapy in infants, toddlers, and preschool‐aged children with type 1 diabetes

  2006cited by this paper
• Safety of insulin glulisine when given by continuous subcutaneous infusion using an external pump in patients with type 1 diabetes.

  2006cited by this paper
• Risk and benefits of continuous subcutaneous insulin infusion (CSII) treatment in school children and adolescents

  2006cited by this paper
• Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH‐based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5‐nations trial

  2006cited by this paper
• Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study

  2006cited by this paper
• Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

  2006cited by this paper
• Glycaemic control with modified intensive insulin injections (MII) using insulin pens and premixed insulin in children with type-1 diabetes: a randomized controlled trial.

  2006cited by this paper
• A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir.

  2005cited by this paper
• Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.

  2005cited by this paper
• Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association.

  2005cited by this paper
• A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes

  2005cited by this paper
• Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine.

  2005cited by this paper
• A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes.

  2005cited by this paper
• Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes.

  2005cited by this paper
• Systematic review and meta-analysis of short-acting insulin analogues in patients with diabetes mellitus.

  2005cited by this paper
• Comparison of three multiple injection regimens for Type 1 diabetes: morning plus dinner or bedtime administration of insulin detemir vs. morning plus bedtime NPH insulin

  2005cited by this paper
• Continuous subcutaneous insulin infusion versus multiple daily injections: modeling predicted benefits in relationship to baseline A1c.

  2005cited by this paper
• Efficacy and safety of insulin glulisine in patients with type 1 diabetes.

  2005cited by this paper
• Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes.

  2005cited by this paper
• [Management of children and adolescents with diabetes mellitus: personal experience].

  2005cited by this paper
• Lower within‐subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes

  2005cited by this paper
• Insulin detemir used in basal‐bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin

  2005cited by this paper
• Insulin glulisine provides improved glycemic control in patients with type 2 diabetes.

  2004cited by this paper
• Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.

  2004cited by this paper
• A direct efficacy and safety comparison of insulin aspart, human soluble insulin, and human premix insulin (70/30) in patients with type 2 diabetes.

  2004cited by this paper
• A randomized, controlled study of insulin pump therapy in diabetic preschoolers.

  2004cited by this paper
• Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK.

  2004cited by this paper
• Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargine.

  2004cited by this paper
• Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes

  2004cited by this paper
• Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy.

  2004cited by this paper
• Dietary Management for Children and Adolescents with Diabetes Mellitus: Personal Experience and Recommendations

  2003cited by this paper
• A comparison of postprandial and preprandial administration of insulin aspart in children and adolescents with type 1 diabetes.

  2003cited by this paper
• Insulin pump therapy: a meta-analysis.

  2003cited by this paper
• Are analogue insulins better than soluble in continuous subcutaneous insulin infusion? Results of a meta‐analysis

  2003cited by this paper
• Randomized cross-over trial of insulin glargine plus lispro or NPH insulin plus regular human insulin in adolescents with type 1 diabetes on intensive insulin regimens.

  2003cited by this paper
• Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.

  2003cited by this paper
• Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog)

  2003cited by this paper
• The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.

  2003cited by this paper
• A one-year, randomised, multicentre trial comparing insulin glargine with NPH insulin in combination with oral agents in patients with type 2 diabetes.

  2003cited by this paper
• Glycaemic control in type 2 diabetes.

  2002cited by this paper
• Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus.

  2002cited by this paper
• Variability of Insulin Absorption and Insulin Action

  2002cited by this paper
• Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes.

  2002cited by this paper
• Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials

  2002cited by this paper
• A direct comparison of insulin aspart and insulin lispro in patients with type 1 diabetes.

  2002cited by this paper
• Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groups

  2002cited by this paper
• Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes.

  2001cited by this paper
• Treatment satisfaction and psychological well‐being with insulin glargine compared with NPH in patients with Type 1 diabetes

  2001cited by this paper
• Good metabolic control is associated with better quality of life in 2,101 adolescents with type 1 diabetes.

  2001cited by this paper
• Use of insulin pumps in pregnancies complicated by type 2 diabetes and gestational diabetes in a multiethnic community.

  2001cited by this paper
• A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents.

  2001cited by this paper
• Insulin aspart vs. human insulin in the management of long‐term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial

  2000cited by this paper
• Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

  2000cited by this paper
• Intensive blood glucose control reduced type 2 diabetes mellitus–related end points

  1999cited by this paper
• Early intensive insulin treatment for induction of long‐term glycaemic control in type 2 diabetes

  1999cited by this paper
• Use of Lispro Insulin and Quality of Life in Adolescents on Intensive Therapy

  1999cited by this paper
• Meta-Analysis of the Effect of Insulin Lispro on Severe Hypoglycemia in Patients With Type 1 Diabetes

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Insulin Lispro in CSII: Results of a Double-Blind Crossover Study

  1997cited by this paper
• Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.

  1997cited by this paper
• Clinical outcomes with insulin lispro compared with human regular insulin: a meta-analysis.

  1997cited by this paper
• Effectiveness of postprandial Humalog in toddlers with diabetes.

  1997cited by this paper
• Efficacy of insulin lispro in combination with NPH human insulin twice per day in patients with insulin-dependent or non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.

  1997cited by this paper
• The Action Profiles of Human NPH Insulin Preparations

  1989cited by this paper

• Knowledge and Practices of Insulin Injection and Medical Waste Disposal Among Patients with Diabetes in Al-Ahsa, Saudi Arabia: a Cross-Sectional Study

  2025cites this paper
• Study to Find the Effectiveness of Standard Protocol Regarding Administration of Insulin Subcutaneously to Type-I Diabetic Patients to Enhance Knowledge among B.Sc. Nursing Students

  2025cites this paper
• Proteomic Changes to the Updated Discovery of Engineered Insulin and Its Analogs: Pros and Cons

  2022cites this paper
• Lentivirus mediated pancreatic beta-cell specific insulin gene therapy for STZ-induced Diabetes.

  2020cites this paper
• Assessment of Insulin Injection Technique Among Diabetic Patients in Makkah Region in Saudi Arabia

  2020cites this paper
• Simple Protocol to Initiate and Intensify Insulin in Primary Care

  2019cites this paper
• DIABETES MELLITUS TREATMENT: A RAPID REVIEW ON INNOVATIVE THERAPIES

  2019cites this paper
• Antidiabetic Activity and Chemical Composition of Sanbai Melon Seed Oil

  2018cites this paper
• Impact of a Novel Insulin Management Service on Non-insulin Pharmaceutical Expenses

  2018cites this paper
• Cost-effectiveness of insulin analogs from the perspective of the Brazilian public health system

  2017cites this paper
• Assessment of Insulin Injection Practice among Diabetes Patients in a Tertiary Healthcare Centre in Nepal: A Preliminary Study

  2017cites this paper
• Forum for Injection Technique (FIT), India: The Indian recommendations 2.0, for best practice in Insulin Injection Technique, 2015

  2015cites this paper
• Results of glycated hemoglobin during treatment with insulin analogues dispensed in the public health system of Federal District in Brazil

  2015cites this paper
• The Role Of Authoritative Parenting In Type 1 Diabetes Adolescent Outcomes

  2014influential citation
• Première année de suivi des patients diabétiques de type 2 mis sous insuline en vie réelle (étude CREDIT-France)

  2014cites this paper
• The effect of snacking on continuously monitored glucose concentrations in analogue insulin basal bolus treatment regimens

  2014influential citation
• Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries

  2013cites this paper
• Perceptions of Usability and Design for Prefilled Insulin Delivery Devices for Patients With Type 2 Diabetes

  2013cites this paper
• Human insulin versus porcine insulin in rhesus monkeys with diabetes mellitus

  2013cites this paper
• An acute need for awareness of insulin injection guidelines in operative and intensive care units

  2013cites this paper
• Clinical utility of insulin and insulin analogs

  2013cites this paper
• Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries

  2013cites this paper
• Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries

  2013cites this paper
• Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries

  2013cites this paper
• Resource utilisation and clinical data before and after switching between short-acting human insulin and rapid-acting insulin analogues in patients with type 2 diabetes: the SWING study.

  2012cites this paper
• Current insulin analogues in the treatment of diabetes: emphasis on type 2 diabetes

  2012cites this paper
• Factors influencing initial choice of insulin therapy in a large international non-interventional study of people with type 2 diabetes

  2012influential citation
• Forum for Injection Techniques, India: The First Indian Recommendations for Best Practice in Insulin Injection Technique

  2012cites this paper
• Análogos de insulina: relevancia clínica y perspectivas futuras Insulin analogues: clinical relevance and future perspectives

  2012cites this paper
• Higher Morning to Evening Ratio in Total Dose of Twice-Daily Biphasic Insulin Analog Might Be Effective in Achieving Glucose Control in Patients with Poorly Controlled Type 2 Diabetes

  2012cites this paper
• Special Considerations for the Use of Insulin in Older Adults

  2011cites this paper
• Which insulin, regimen and device in type 2 diabetes?

  2010influential citation
• Diabetes mellitus: new challenges and innovative therapies

  2010cites this paper
• Cost-effectiveness of switching to biphasic insulin aspart from human premix insulin in a US setting

  2010cites this paper
• Clinical and laboratory profile of pediatric and adolescent patients with type 1 diabetes.

  2009cites this paper
• New insulins and newer insulin regimens: a review of their role in improving glycaemic control in patients with diabetes

  2009cites this paper
• Vascular Health and Risk Management Dovepress Insulin Degludec/insulin Aspart Combination for the Treatment of Type 1 and Type 2 Diabetes

  year unknowncites this paper